Abcellera Biologics Stock Forecast - Price Action Indicator
| ABCL Stock | USD 4.24 0.40 8.62% |
Abcellera Stock outlook is based on your current time horizon. Although Abcellera Biologics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Abcellera Biologics' systematic risk associated with finding meaningful patterns of Abcellera Biologics fundamentals over time.
As of now, the RSI of Abcellera Biologics' share price is approaching 48. This suggests that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Abcellera Biologics, making its price go up or down. Momentum 48
Impartial
Oversold | Overbought |
Quarterly Earnings Growth 0.459 | EPS Estimate Next Quarter (0.16) | EPS Estimate Current Year (0.65) | EPS Estimate Next Year (0.69) | Wall Street Target Price 9.8333 |
Using Abcellera Biologics hype-based prediction, you can estimate the value of Abcellera Biologics from the perspective of Abcellera Biologics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Abcellera Biologics using Abcellera Biologics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Abcellera using crowd psychology based on the activity and movement of Abcellera Biologics' stock price.
Abcellera Biologics Short Interest
An investor who is long Abcellera Biologics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Abcellera Biologics and may potentially protect profits, hedge Abcellera Biologics with its derivative instruments, or be ready for some potential downside.
200 Day MA 3.8679 | Short Percent 0.2091 | Short Ratio 15.08 | Shares Short Prior Month 50.5 M | 50 Day MA 3.7646 |
Abcellera Relative Strength Index
Abcellera Biologics Hype to Price Pattern
Investor biases related to Abcellera Biologics' public news can be used to forecast risks associated with an investment in Abcellera. The trend in average sentiment can be used to explain how an investor holding Abcellera can time the market purely based on public headlines and social activities around Abcellera Biologics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Abcellera Biologics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Abcellera Biologics.
Abcellera Biologics Implied Volatility | 1.27 |
Abcellera Biologics' implied volatility exposes the market's sentiment of Abcellera Biologics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Abcellera Biologics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Abcellera Biologics stock will not fluctuate a lot when Abcellera Biologics' options are near their expiration.
Abcellera Biologics after-hype prediction price | USD 4.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Abcellera | Build AI portfolio with Abcellera Stock |
Prediction based on Rule 16 of the current Abcellera contract
Based on the Rule 16, the options market is currently suggesting that Abcellera Biologics will have an average daily up or down price movement of about 0.0794% per day over the life of the 2026-04-17 option contract. With Abcellera Biologics trading at USD 4.24, that is roughly USD 0.003366 . If you think that the market is fully incorporating Abcellera Biologics' daily price movement you should consider acquiring Abcellera Biologics options at the current volatility level of 1.27%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Open Interest Against 2026-04-17 Abcellera Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Abcellera Biologics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Abcellera Biologics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Abcellera Biologics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Abcellera Biologics' open interest, investors have to compare it to Abcellera Biologics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Abcellera Biologics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Abcellera. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Abcellera Biologics Additional Predictive Modules
Most predictive techniques to examine Abcellera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Abcellera using various technical indicators. When you analyze Abcellera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.39) | (0.39) |
| Check Abcellera Biologics Volatility | Backtest Abcellera Biologics | Information Ratio |
Abcellera Biologics Trading Date Momentum
| On January 26 2026 Abcellera Biologics was traded for 4.24 at the closing time. The top price for the day was 4.67 and the lowest listed price was 4.19 . There was no trading activity during the period 0.0. Lack of trading volume on January 26, 2026 did not affect price variability. The overall trading delta against the current closing price is 9.43% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Abcellera Biologics to competition |
Other Forecasting Options for Abcellera Biologics
For every potential investor in Abcellera, whether a beginner or expert, Abcellera Biologics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Abcellera Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Abcellera. Basic forecasting techniques help filter out the noise by identifying Abcellera Biologics' price trends.Abcellera Biologics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Abcellera Biologics stock to make a market-neutral strategy. Peer analysis of Abcellera Biologics could also be used in its relative valuation, which is a method of valuing Abcellera Biologics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Abcellera Biologics Market Strength Events
Market strength indicators help investors to evaluate how Abcellera Biologics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Abcellera Biologics shares will generate the highest return on investment. By undertsting and applying Abcellera Biologics stock market strength indicators, traders can identify Abcellera Biologics entry and exit signals to maximize returns.
Abcellera Biologics Risk Indicators
The analysis of Abcellera Biologics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Abcellera Biologics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting abcellera stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.14 | |||
| Standard Deviation | 4.31 | |||
| Variance | 18.54 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Abcellera Biologics
The number of cover stories for Abcellera Biologics depends on current market conditions and Abcellera Biologics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Abcellera Biologics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Abcellera Biologics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Abcellera Biologics Short Properties
Abcellera Biologics' future price predictability will typically decrease when Abcellera Biologics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Abcellera Biologics often depends not only on the future outlook of the potential Abcellera Biologics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Abcellera Biologics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 294.3 M | |
| Cash And Short Term Investments | 625.6 M |
Check out Historical Fundamental Analysis of Abcellera Biologics to cross-verify your projections. For more information on how to buy Abcellera Stock please use our How to buy in Abcellera Stock guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abcellera Biologics. If investors know Abcellera will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abcellera Biologics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.459 | Earnings Share (0.57) | Revenue Per Share | Quarterly Revenue Growth 0.376 | Return On Assets |
The market value of Abcellera Biologics is measured differently than its book value, which is the value of Abcellera that is recorded on the company's balance sheet. Investors also form their own opinion of Abcellera Biologics' value that differs from its market value or its book value, called intrinsic value, which is Abcellera Biologics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abcellera Biologics' market value can be influenced by many factors that don't directly affect Abcellera Biologics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abcellera Biologics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Abcellera Biologics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abcellera Biologics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.